9-aminocamptothecin has been researched along with Adenocarcinoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avadhani, A; Karrison, T; Kindler, HL; Mani, S; Vokes, EE; Wade-Oliver, K | 1 |
| Lehr, JE; Naik, H; Pienta, KJ | 1 |
| Abbruzzese, JL; Arbuck, SG; Ballard, WP; Bradof, JE; Diaz-Canton, E; Graham, S; Pazdur, R; Winn, R | 1 |
| Balcerzak, SP; Kraut, EH; Kuebler, JP; Mayernik, DG; O'Rourke, MA; Petrus, JJ; Young, D | 1 |
3 trial(s) available for 9-aminocamptothecin and Adenocarcinoma
| Article | Year |
|---|---|
9-Aminocamptothecin (9-AC) given as a 120-hour continuous infusion in patients with advanced adenocarcinomas of the stomach and gastroesophageal junction: A phase II trial of the University of Chicago phase II consortium.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Camptothecin; Esophageal Neoplasms; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Stomach Neoplasms; Survival Rate; Treatment Outcome | 2004 |
Phase II trial of 9-aminocamptothecin administered as a 72-hour continuous infusion in metastatic colorectal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Camptothecin; Colorectal Neoplasms; Drug Administration Schedule; Female; Humans; Infusion Pumps; Infusions, Intravenous; Male; Middle Aged | 1997 |
A phase II study of 9-aminocamptothecin in patients with refractory breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Camptothecin; Female; Humans; Infusions, Intravenous; Middle Aged; Treatment Outcome | 2000 |
1 other study(ies) available for 9-aminocamptothecin and Adenocarcinoma
| Article | Year |
|---|---|
Inhibition of prostate cancer growth by 9-aminocamptothecin and estramustine.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Division; Estramustine; Humans; Male; Prostatic Neoplasms; Rats | 1996 |